GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLASCO Taiwan Co Ltd (ROCO:6662) » Definitions » EBITDA Margin %

BioLASCO Taiwan Co (ROCO:6662) EBITDA Margin % : 15.46% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BioLASCO Taiwan Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. BioLASCO Taiwan Co's EBITDA for the three months ended in Mar. 2024 was NT$7.4 Mil. BioLASCO Taiwan Co's Revenue for the three months ended in Mar. 2024 was NT$47.7 Mil. Therefore, BioLASCO Taiwan Co's EBITDA margin for the quarter that ended in Mar. 2024 was 15.46%.


BioLASCO Taiwan Co EBITDA Margin % Historical Data

The historical data trend for BioLASCO Taiwan Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLASCO Taiwan Co EBITDA Margin % Chart

BioLASCO Taiwan Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.52 29.73 29.58 27.21 27.90

BioLASCO Taiwan Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.24 27.50 28.51 30.61 15.46

Competitive Comparison of BioLASCO Taiwan Co's EBITDA Margin %

For the Biotechnology subindustry, BioLASCO Taiwan Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLASCO Taiwan Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLASCO Taiwan Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where BioLASCO Taiwan Co's EBITDA Margin % falls into.



BioLASCO Taiwan Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

BioLASCO Taiwan Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=73.856/264.723
=27.90 %

BioLASCO Taiwan Co's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=7.377/47.717
=15.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioLASCO Taiwan Co  (ROCO:6662) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


BioLASCO Taiwan Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of BioLASCO Taiwan Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLASCO Taiwan Co (ROCO:6662) Business Description

Traded in Other Exchanges
N/A
Address
3rd Floor, 316 Chong-yang Road, Taipei, TWN, 115
BioLASCO Taiwan Co Ltd is a biological experimental development company. The company has produced strains of laboratory rats and mice, including outbreed stocks, inbreed strains, and immunedeficient models. It offers reagent kit and equipment which include Allentown, Biomedical data system, PLAS LABS.

BioLASCO Taiwan Co (ROCO:6662) Headlines

No Headlines